Literature DB >> 6432540

A simple and safe technique for sterile autologous platelet labelling using "Monovette" vials.

H Sinzinger, H Kolbe, E Strobl-Jäger, R Höfer.   

Abstract

A simple technique of autologous platelet labelling is described, which allows labelling within 40 min, and has the advantage of low costs, as no laminar air flow is required. Blood (16 ml) was withdrawn into 4 ml ACD, 500 ng prostacyclin was added. After 10 min sedimentation the vials were centrifuged for 5 min at 150 g. The plateletrich plasma in the supernatant was centrifuged at 500 g for 10 min to obtain a platelet pellet. The platelet-poor plasma was preserved in a sterile syringe and the platelet pellet was resuspended in 1 ml tyrode buffer. The cell suspension was labelled at 37 degrees C for 5 min with 100 muCi 111In-oxine sulphate and reinjected after dilution with the plasma. Mean labelling efficiency was 90% +/- 3%, mean recovery 2 h after reinjection 76% +/- 3% (mean +/- SD).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432540     DOI: 10.1007/bf00276462

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  7 in total

1.  Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions.

Authors:  M L Thakur; M J Welch; J H Joist; R E Coleman
Journal:  Thromb Res       Date:  1976-10       Impact factor: 3.944

2.  Influence of incubation time and temperature on indium-111-oxide uptake by human platelets.

Authors:  H Sinzinger; P Angelberger; H Kolbe
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

3.  Preparation of a viable population of indium-111-labelled human blood platelets.

Authors:  A D Heyns; P N Badenhorst; H Pieters; M G Lötter; P C Minnaar; L J Duyvené de Wit; O R Van Reenen; F P Retief
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249

4.  Use of indium-111/oxine to label human platelets.

Authors:  R J Hawker; L M Hawker; A R Wilkinson
Journal:  Lancet       Date:  1978-08-26       Impact factor: 79.321

5.  Indium (111In)-labelled human platelets: optimal method.

Authors:  R J Hawker; L M Hawker; A R Wilkinson
Journal:  Clin Sci (Lond)       Date:  1980-03       Impact factor: 6.124

6.  [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].

Authors:  E Jäger; H Sinzinger; K Widhalm; J Kaliman; R Höfer
Journal:  Wien Klin Wochenschr       Date:  1982-09-03       Impact factor: 1.704

7.  Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets.

Authors:  H H Davis; W A Heaton; B A Siegel; C J Mathias; J H Joist; L A Sherman; M J Welch
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

  7 in total
  10 in total

Review 1.  Nuclear medicine and atherosclerosis.

Authors:  H Sinzinger; I Virgolini
Journal:  Eur J Nucl Med       Date:  1990

2.  Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.

Authors:  H Sinzinger; F Rauscha; J O'Grady; P Fitscha
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  Autologous platelet labelling using "Monovette" vials is not septic.

Authors:  H Sinzinger; E Strobl-Jäger; R Höfer
Journal:  Eur J Nucl Med       Date:  1986

4.  Stabilization of endothelial lining and decrease in circulating endothelial cells--one mechanism underlying the clinical action of PGE1?

Authors:  H Sinzinger; I Virgolini; P Fitscha; F Rauscha; J Kaliman
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

5.  A septic labelling of thrombocytes.

Authors:  P H Vree
Journal:  J Nucl Med       Date:  1985       Impact factor: 10.057

6.  Beneficial effect of PGI2 on circulating endothelial cells.

Authors:  H Sinzinger; F Rauscha; P Fitscha; J Kaliman
Journal:  Basic Res Cardiol       Date:  1988 Nov-Dec       Impact factor: 17.165

7.  Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in man.

Authors:  H Sinzinger; P Fitscha; J Kaliman; K Silberbauer; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

8.  111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia.

Authors:  H Louwes; H Beekhuis; W T Goedemans; S P Keijser; J J Schuurman
Journal:  Eur J Nucl Med       Date:  1987

9.  Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivo.

Authors:  H Sinzinger; J O'Grady; P Fitscha
Journal:  Postgrad Med J       Date:  1987-04       Impact factor: 2.401

10.  Platelet viability (aggregation, migration, recovery) after radiolabelling from hypercholesterolemics using various tracers (oxine, oxine-sulphate, tropolone, MPO).

Authors:  H Sinzinger; J Flores; K Widhalm; S Granegger
Journal:  Eur J Nucl Med       Date:  1988
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.